Iyer Health Reports Early Clinical Findings: 15 Cases of Hidden Coronary Disease Detected via Precision Screening

HERNDON, VA, August 20, 2026 (EZ Newswire) -- Less than two months after opening its doors on June 1, 2026, suburban Virginia precision-medicine practice Iyer Health has released early observational tracking metrics from its newly launched Body for Life™ program. During its first eight weeks of operation, the physician-directed program identified 15 previously unrecognized cases of severe coronary artery disease, while its clinical team reported averting four imminent cardiac events and successfully resuscitating one patient from sudden cardiac arrest.

Created by Harvard-trained physician-scientist Ravi R. Iyer, MD, Body for Life integrates advanced biomarker analysis, biological-age assessments, regenerative medicine, and AI-assisted predictive risk modeling. The program operates as a direct-pay precision layer designed to complement standard, insurance-based primary care by identifying subclinical cardiovascular risk before symptomatic disease develops.

“The greatest victory in medicine is the heart attack that never happens,” said Dr. Iyer, founder of Iyer Health. “Direct-pay precision medicine allows us to price prevention transparently, using modern predictive tools to measure biological risk earlier and intervene before a health issue turns into a critical emergency.”

First 60-Day Program Tracking

Data gathered through internal program tracking from June 1 through July 31, 2026, revealed the following clinical observations among early program participants:

• 15 cases of previously unrecognized severe coronary artery disease identified
• 4 high-risk cardiac events reported averted through early detection and clinical intervention
• 1 sudden cardiac arrest successfully resuscitated on-site and transferred for emergency care
• 20 patients with severe vascular disease initiated on targeted risk-reduction protocols
• 30 patients enrolled in physician-supervised weight-management programs, recording 218.8 lbs of collective weight loss over a 30-day period
• 5 patients with prior sleep apnea diagnoses reassessed by treating clinicians as no longer requiring CPAP support
• 4 patients with gout achieved normalized uric acid levels during treatment

Foundation in Predictive Health

The core risk-forecasting methodology powering Body for Life stems from the COMANCHE Score (COMorbidity-Adjusted Non-Critical Health Evaluation), an outpatient risk-stratification algorithm originally developed by Dr. Iyer in 1995. Modeled on the ICU-based APACHE scoring framework, COMANCHE evaluates routine outpatient data points to forecast clinical deterioration before hospital admission is required.

In an early pilot conducted with HCA Columbia’s Reston Hospital from 1997 to 1998, an automated monitoring platform utilizing the COMANCHE algorithm tracked 13 high-risk congestive heart failure (CHF) patients. The cohort reduced hospital admissions from 124 combined visits in the year prior to enrollment down to 2 total admissions during the program year. Within Body for Life, this predictive framework has been updated to run on the Ayora Score AI engine from Ayora Health LLC, integrating multi-omic testing, advanced genomic markers, and continuous biomarker monitoring.

By offering these advanced diagnostics through a direct-pay model, Iyer Health aims to provide patients with dedicated longitudinal attention while addressing systemic limitations inherent to traditional fee-for-service reimbursement structures.

About Iyer Health

Iyer Health is an integrated healthcare ecosystem founded by Harvard-trained physician-scientist Ravi R. Iyer, MD, combining accessible insurance reimbursed primary care through The Iyer Clinic with physician-directed Direct Pay-precision longevity medicine through Body for Life a separate service of Nova Health Management & Research Group under a single operational roof. Its stated mission is to shift healthcare from single reactive treatment model towards a complementary binary model of a predictive prevention and lifelong vitality platform that is priced and delivered separately and co-equally with the reactive treatment insurance model. Ayora Score and COMANCHE algorithm are components of Ayora Health LLC’s Intelligent AI engine program. Body for Life™ — Your Best Life, Today. For more information, visit iyerhealth.com.

Disclaimer

The information in this release is provided for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment, nor as a substitute for consultation with a qualified healthcare professional. Clinical outcomes and program figures cited are based on Iyer Health’s internal tracking and clinical observations and have not been independently audited, validated in a controlled clinical trial, or published in a peer-reviewed study. Statements regarding events believed to have been prevented or averted reflect the clinical team’s assessment and do not establish that such events would otherwise have occurred or that the Body for Life™ program caused any reported outcome. Individual results may vary, and no specific health outcome, prevention of disease, improvement in longevity, or extension of lifespan is guaranteed. References to predictive modeling, artificial intelligence, biomarkers, biological-age assessments, genomic or molecular testing, functional medicine, regenerative medicine, or other emerging approaches should not be interpreted as claims that these methods can predict, prevent, cure, or eliminate any disease with certainty. Historical program results, including those attributed to PREDICT, COMANCHE, or prior hospital initiatives, are presented as reported historical observations and should not be interpreted as evidence of current clinical efficacy. Patients should consult their treating healthcare professionals before making decisions about medical care, medications, CPAP use, weight management, alcohol or tobacco cessation, or other health interventions.

Media Contact

Iyer Health
layline.scaliem@iyerclinic.com